<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <title>Pipeline - Nirmedix Mock</title>
  <link rel="stylesheet" href="assets/styles.css" />
</head>
<body>
  <header class="site-header">
    <div class="container">
      <a class="logo" href="index.html"><img src="assets/logo-free.png" alt="Nirmedix"></a>
      <nav class="main-nav">
        <a href="index.html">Home</a>
        <a href="pipeline.html">Pipeline</a>
        <a href="about.html">About</a>
        <a href="index.html#contact">Contact</a>
      </nav>
    </div>
  </header>

  <main class="container">
    <h1>Pipeline</h1>

    <section id="nmx-101" class="pipeline-item">
      <h2>NMX-101</h2>
      <p><strong>Indication</strong> Oncology</p>
      <p><strong>Stage</strong> Phase 2</p>
      <p>NMX-101 is a selective inhibitor of the X pathway with demonstrated tumor regression in preclinical models.</p>
    </section>

    <section id="nmx-202" class="pipeline-item">
      <h2>NMX-202</h2>
      <p><strong>Indication</strong> Rare metabolic disorder</p>
      <p><strong>Stage</strong> Preclinical</p>
      <p>NMX-202 targets enzyme Y to restore metabolic balance in disease models.</p>
    </section>
  </main>

  <footer class="site-footer">
    <div class="container">
      <p><strong>Content licensed for free use.</strong></p>
      <p>&copy; <span id="year2"></span> Nirmedix Pharmaceuticals.</p>
    </div>
  </footer>

  <script src="assets/script.js"></script>
</body>
</html>
